Molecular marker for early warning of atherosclerosis and application of molecular marker
A technology of atherosclerosis and molecular markers, applied in the medical field, can solve the problem of unclear effect of Hcy on endothelial cell apoptosis, and achieve the effect of helping clinical intervention in time and delaying the development of the disease
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0036] The technical solution of the present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.
[0037] A molecular marker for early warning of atherosclerosis, the specific embodiment is:
[0038] 1 Material preparation
[0039] 1.1 Materials and reagents Human umbilical vein endothelial cells (HUVECs) (China, Mingjin Biotechnology Co., Ltd.); homocysteine (US, Sigma); fetal bovine serum, DMEM medium (Australia, Gibco); Streptomycin, trypsin digestion solution, NP-40 (ethylphenyl polyethylene glycol) (China, Beyentian Biotechnology Research Institute); Cell Viability Fluorescence Assay Kit (Switzerland, Roche Company); PMSF (China, Beijing Suolaibao Technology Co., Ltd.); Bax (Bcl-2-related X protein) antibody, Bcl-2 (B lymphocytoma-2) antibody (UK, Abcam), β-actin antibody, horseradish peroxidase Labeled secondary antibody (China, Beijing Jinqiao Co., Ltd.); skimmed milk powder (USA, BD company); c...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com